Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer_

por | Ene 1, 2021 | Publicaciones - BA-14 | 0 Comentarios

Blancas, I; Olier, C; Conde, V; Bayo, JL; Herrero, C; Zarcos-Pedrinaci, I; Carabantes, F; Baena-Canada, JM; Cruz, J; Ruiz-Borrego, M – 2021